M. Gold

31.1k total citations
21 papers, 191 citations indexed

About

M. Gold is a scholar working on Dermatology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, M. Gold has authored 21 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Dermatology, 4 papers in Neurology and 3 papers in Psychiatry and Mental health. Recurrent topics in M. Gold's work include Dermatologic Treatments and Research (4 papers), Dermatology and Skin Diseases (3 papers) and Neurological disorders and treatments (3 papers). M. Gold is often cited by papers focused on Dermatologic Treatments and Research (4 papers), Dermatology and Skin Diseases (3 papers) and Neurological disorders and treatments (3 papers). M. Gold collaborates with scholars based in United States, Denmark and Canada. M. Gold's co-authors include Robert A. Hauser, Theresa A. Zesiewicz, Geetha Chari, R. Hauser, C. Warren Olanow, Mark S. Nestor, Patricia K. Farris, Hema Sundaram, David J. Goldberg and Mary P. Lupo and has published in prestigious journals such as Journal of the American Academy of Dermatology, American Journal of Geriatric Psychiatry and Journal of Neuroimaging.

In The Last Decade

M. Gold

15 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Gold United States 7 119 31 30 27 22 21 191
Daria Kraus Germany 9 143 1.2× 87 2.8× 9 0.3× 33 1.2× 24 1.1× 12 281
Ignacio Casas Parera Argentina 6 145 1.2× 38 1.2× 64 2.1× 12 0.4× 35 1.6× 21 277
V. Simioni Italy 6 74 0.6× 16 0.5× 21 0.7× 11 0.4× 55 2.5× 13 145
Toby C. Yaltho United States 9 324 2.7× 118 3.8× 55 1.8× 21 0.8× 16 0.7× 10 389
Bedia Samancı Türkiye 11 106 0.9× 24 0.8× 37 1.2× 12 0.4× 32 1.5× 45 219
Branislav Veselý Slovakia 6 167 1.4× 38 1.2× 25 0.8× 21 0.8× 39 1.8× 7 210
Patrik Aronsson Sweden 12 18 0.2× 26 0.8× 38 1.3× 21 0.8× 48 2.2× 43 349
B. Greim Germany 9 123 1.0× 41 1.3× 76 2.5× 3 0.1× 25 1.1× 14 302
Niall J Crosby United Kingdom 6 151 1.3× 91 2.9× 22 0.7× 3 0.1× 12 0.5× 11 281
Sanjib Sinha India 9 48 0.4× 27 0.9× 33 1.1× 23 0.9× 18 0.8× 25 330

Countries citing papers authored by M. Gold

Since Specialization
Citations

This map shows the geographic impact of M. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gold more than expected).

Fields of papers citing papers by M. Gold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gold. The network helps show where M. Gold may publish in the future.

Co-authorship network of co-authors of M. Gold

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gold. A scholar is included among the top collaborators of M. Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gold. M. Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gold, M., et al.. (2025). AI3D Co-Create with AI3D Render. 1–3. 1 indexed citations
2.
3.
Auranen, Annika, Lyndsay Willmott, David Cibula, et al.. (2024). 37MO Dostarlimab plus chemotherapy in primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: Overall survival (OS) by MMR status and molecular subgroups. ESMO Open. 9. 103537–103537. 3 indexed citations
4.
Eldik, Linda J. Van, Eric Siemers, Emily C. Collins, et al.. (2024). Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(4). e70014–e70014. 1 indexed citations
5.
Burgess, Cheryl, M. Gold, Patricia K. Farris, Adina Hazan, & Isabelle Raymond‐Letron. (2024). A Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical.. PubMed. 23(3). 160–167. 3 indexed citations
6.
7.
Kircik, Leon, Linda Stein Gold, M. Gold, et al.. (2024). Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis. Dermatology and Therapy. 14(5). 1211–1227.
8.
Gold, M., Anneke Andriessen, Edward Lain, et al.. (2024). INDIVIDUAL ARTICLE: Real-World Patient Cases Using Triple Lipid-Containing Cream for Cutaneous Healing Post Laser or Microneedling Radiofrequency Treatment.. PubMed. 23(9). 68821s3–68821s14. 2 indexed citations
9.
Patil, Anant, George Kroumpouzos, Hassan Galadari, et al.. (2022). Hormonal Therapies in the Management of Acne Vulgaris. Journal of Drugs in Dermatology. 21(6). 618–623. 2 indexed citations
10.
Gold, M., et al.. (2022). Supplement Individual Article: Algorithm for Pre-/Post-Procedure Measures in Racial/Ethnic Populations Treated With Facial Lasers, Nonenergy Devices, or Injectables.. PubMed. 21(10). SF3509903–SF35099011. 6 indexed citations
11.
Gold, M., Melinda Gooderham, Leon Kircik, et al.. (2021). Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase). Journal of Drugs in Dermatology. 20(4). 436–441. 5 indexed citations
12.
Alonso‐Llamazares, Javier, et al.. (2021). Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation. Journal of Drugs in Dermatology. 21(1). 13–20. 1 indexed citations
13.
Gold, M. & Mark S. Nestor. (2020). A Supersaturated Oxygen Emulsion for Wound Care and Skin Rejuvenation. Journal of Drugs in Dermatology. 19(3). 250–253. 7 indexed citations
14.
Smith, Stacy, et al.. (2020). Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results. Journal of Drugs in Dermatology. 19(10). 969–976.
15.
Gold, M., et al.. (2020). Development and Evaluation of an Atopic Dermatitis Care Plan for Providers. Journal of Drugs in Dermatology. 19(10). 950–955.
16.
Zesiewicz, Theresa A., M. Gold, Geetha Chari, & R. Hauser. (1999). Current issues in depression in Parkinson's disease.. PubMed. 7(2). 110–8. 45 indexed citations
17.
Zesiewicz, Theresa A., et al.. (1999). Current Issues in Depression in Parkinsonʼs Disease. American Journal of Geriatric Psychiatry. 7(2). 110–118. 14 indexed citations
18.
Gold, M., et al.. (1998). Plasma Thiamine Deficiency Associated with Alzheimer's Disease but Not Parkinson's Disease. Metabolic Brain Disease. 13(1). 43–53. 44 indexed citations
19.
Hauser, Robert A., et al.. (1996). Magnetic Resonance Imaging of Corticobasal Degeneration. Journal of Neuroimaging. 6(4). 222–226. 49 indexed citations
20.
Johnson, Howard L., et al.. (1993). A Guide to Procurement of Trusted Systems: Language for RFP Specifications and Statements of Work- An Aid to Procurement Initiators.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daria Kraus Breakdown of academic impact, for papers by Ignacio Casas Parera Breakdown of academic impact, for papers by V. Simioni Breakdown of academic impact, for papers by Toby C. Yaltho Breakdown of academic impact, for papers by Bedia Samancı Breakdown of academic impact, for papers by Branislav Veselý Breakdown of academic impact, for papers by Patrik Aronsson Breakdown of academic impact, for papers by B. Greim Breakdown of academic impact, for papers by Niall J Crosby Breakdown of academic impact, for papers by Sanjib Sinha
Rankless by CCL
2026